EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Recurrent cardiac tamponade following coronavirus disease 2019 mRNA vaccination: A case report

Ryo Kaimori, Haruto Nishida, Takaaki Yahiro, Takashi Miura, Takahiro Iwami, Tsutomu Daa

Cardiovascular Pathology · 2024

DOI: 10.1016/j.carpath.2024.107668 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cardiovascular Pathology, 2024. Verfasst von Ryo Kaimori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine, Faculty of Medicine, Oita University, Yufu, Oita, Japan; Department of Diagnostic Pathology, Faculty of Medicine, Oi…. Hauptthemen laut MEDLINE: Cardiac Tamponade, COVID-19, SARS-CoV-2, 2019-nCoV Vaccine mRNA-1273. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 64-year-old woman with a history of subarachnoid hemorrhage, breast cancer, cervical spine tumor, and syringomyelia developed recurrent pericardial effusion and cardiac tamponade after receiving the third dose of coronavirus disease 2019 mRNA vaccine, mRNA-1273 (Spikevax, Moderna). The cardiac tamponade of unknown etiology was intractable with nonsteroidal anti-inflammatory drugs, colchicine, and prednisolone. She underwent thoracoscopic pericardiectomy, and microthrombi were detected in the pericardial tissue. Although the exact causal relationship between vaccination and recurrent cardiac tamponade was unclear, the vaccine possibly caused or triggered the microthrombi formation, resulting in recurrent cardiac tamponade. Because of the potential for cardiovascular side effects such as thrombosis and myocarditis following vaccination, it was deemed necessary to accumulate and analyze such cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac TamponadeCOVID-19SARS-CoV-22019-nCoV Vaccine mRNA-1273RecurrenceHumansFemaleMiddle AgedCOVID-19 VaccinesVaccinationPericardial EffusionTreatment OutcomePericardiectomy

Stichwörter der Autor:innen

COVID-19 mRNA vaccineCardiac tamponadeThrombosis

Substanzen

2019-nCoV Vaccine mRNA-1273COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Forensic Medicine, Faculty of Medicine, Oita University, Yufu, Oita, Japan; Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Oita, Japan.
  • Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Oita, Japan. Electronic address: nharuto@oita-u.ac.jp.
  • Department of Microbiology, Faculty of Medicine, Oita University, Yufu, Oita, Japan; Department of Advanced Medical Sciences, Faculty of Medicine, Oita University, Yufu, Oita, Japan; Division of One Health, The Research…
  • Department of Thoracic Surgery, Oita City Medical Association's Almeida Memorial Hospital, Oita, Oita, Japan.
  • Department of Cardiology, Mie hospital, Bungo-Ohno, Oita, Japan.
  • Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Yufu, Oita, Japan.

Zitieren

APA

Kaimori, R., Nishida, H., Yahiro, T., Miura, T., Iwami, T., & Daa, T. (2024). Recurrent cardiac tamponade following coronavirus disease 2019 mRNA vaccination: A case report. Cardiovascular Pathology. https://doi.org/10.1016/j.carpath.2024.107668

Vancouver

Kaimori R, Nishida H, Yahiro T, Miura T, Iwami T, Daa T. Recurrent cardiac tamponade following coronavirus disease 2019 mRNA vaccination: A case report. Cardiovascular Pathology. 2024. doi:10.1016/j.carpath.2024.107668

BibTeX
@article{Kaimori2024,
  author = {Kaimori, Ryo and Nishida, Haruto and Yahiro, Takaaki and Miura, Takashi and Iwami, Takahiro and Daa, Tsutomu},
  title = {Recurrent cardiac tamponade following coronavirus disease 2019 mRNA vaccination: A case report},
  journal = {Cardiovascular Pathology},
  year = {2024},
  doi = {10.1016/j.carpath.2024.107668}
}
Kostenlos starten →